Pancreatic cancer study tracks why it comes back so fast after surgery

NCT ID NCT07241676

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Azienda Ospedaliera di Padova Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 adults with pancreatic cancer who had surgery intended to remove all visible cancer. Researchers want to learn how often the cancer returns within the first year, where it shows up (like the liver or lungs), and how it is detected. Participants receive standard follow-up care, and no new treatments are tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict which patients are likely to have early cancer recurrence after surgery, guiding more personalized follow-up and treatment decisions.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may vary across hospitals and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma pancreatic ductal adenocarcinoma Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) RECURRENT PANCREATIC ADENOCARCINOMA

Contacts and locations

Locations

University of Padova

Padova, PD, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.